0001410939-22-000120.txt : 20221205
0001410939-22-000120.hdr.sgml : 20221205
20221205173737
ACCESSION NUMBER: 0001410939-22-000120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221201
FILED AS OF DATE: 20221205
DATE AS OF CHANGE: 20221205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Westby Keith
CENTRAL INDEX KEY: 0001696429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 221446014
MAIL ADDRESS:
STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: (609) 474-6755
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
wf-form4_167027983493997.xml
FORM 4
X0306
4
2022-12-01
0
0001410939
IVERIC bio, Inc.
ISEE
0001696429
Westby Keith
C/O IVERIC BIO, INC.
8 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
SVP & COO
Common Stock
2022-12-01
4
S
0
10030
22.96
D
59759
D
Common Stock
2022-12-02
4
M
0
5199
10.03
A
64958
D
Stock Option (right to buy)
10.03
2022-12-02
4
M
0
5199
10.03
D
2022-12-29
Common Stock
5199.0
0
D
The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $22.62 to $23.84 per share on December 1, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
This total includes 661 shares acquired by the Reporting Person on September 15, 2022 under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
This option was granted on December 29, 2012 and is currently excisable for all shares underlying the option.
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Keith Westby
2022-12-05